Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

about

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

Item

http://www.wikidata.org/entity/Q50853137

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@en

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@nl

type

Item

label

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@en

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@nl

prefLabel

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@en

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@nl

P1476

Results of intravitreal ranibizumab treatment for retinopathy of prematurity in infants.

@en

P2093

Emine Alyamaç Sukgen

http://www.w3.org/2001/XMLSchema#string

Yusuf Koçluk

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.

Reactivation of retinopathy of prematurity after ranibizumab treatment.

Primary intravitreal ranibizumab for high-risk retinopathy of prematurity.

Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.

Pathophysiology and mechanisms of severe retinopathy of prematurity.

Through the eyes of a child: understanding retinopathy through ROP the Friedenwald lecture.

Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.

Spectral-Domain OCT Analyses of Macular Changes After Ranibizumab Therapy for Type 1 Retinopathy of Prematurity.

P304

356-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15569527.2017.1300160

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28277877

http://www.w3.org/2001/XMLSchema#string